And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

PBYI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $728,295.40

Puma Biotechnology Insider Trading History Chart

Puma Biotechnology Share Price & Price History

^$5.13

▼ -0.04 (-0.77%)

As of 04/23/2024 01:00 AM ET

Days: 30 | 90 | 365

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here

Puma Biotechnology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/3/2024	Alan H. Auerbach	CEO	Sell	41,396	$4.49	$185,868.04	6,936,947
1/3/2024	Alvin F. Wong	Insider	Sell	7,733	$4.49	$34,721.17	98,214
1/3/2024	Maximo F. Nougues	CFO	Sell	15,682	$4.49	$70,412.18	128,666
11/7/2023	Michael Patrick Miller	Director	Sell	25,000	$2.83	$70,750.00	43,358
7/3/2023	Alan H. Auerbach	CEO	Sell	60,698	$3.31	$200,910.38	6,978,343
7/3/2023	Alvin F. Wong	Insider	Sell	6,938	$3.31	$22,964.78	105,947
7/3/2023	Maximo F. Nougues	CFO	Sell	14,680	$3.31	$48,590.80	144,348
6/13/2023	Troy Edward Wilson	Director	Sell	27,000	$3.45	$93,150.00	350
6/2/2023	Alvin F. Wong	Insider	Sell	269	$3.45	$928.05	112,885
1/3/2023	Alan H. Auerbach	CEO	Sell	27,241	$4.18	$113,867.38	6,852,638
1/3/2023	Alvin F. Wong	Insider	Sell	3,460	$4.18	$14,462.80	54,553
1/3/2023	Maximo F. Nougues	CFO	Sell	10,499	$4.18	$43,885.82	100,427
11/2/2022	Alan H. Auerbach	CEO	Sell	1,242	$2.25	$2,794.50	6,312,949
11/2/2022	Douglas M. Hunt	Insider	Sell	429	$2.25	$965.25	76,004
11/2/2022	Maximo F. Nougues	CFO	Sell	163	$2.25	$366.75	111,085
10/3/2022	Alan H. Auerbach	CEO	Sell	1,260	$2.34	$2,948.40	6,314,191
10/3/2022	Douglas M. Hunt	Insider	Sell	435	$2.34	$1,017.90	76,433
10/3/2022	Maximo F. Nougues	CFO	Sell	165	$2.34	$386.10	111,248
8/9/2022	Michael Patrick Miller	Director	Sell	25,000	$3.55	$88,750.00	54,858
8/2/2022	Alan H. Auerbach	CEO	Sell	1,247	$2.89	$3,603.83	6,316,705
8/2/2022	Douglas M. Hunt	Insider	Sell	429	$2.89	$1,239.81	77,301
8/2/2022	Maximo F. Nougues	CFO	Sell	161	$2.89	$465.29	111,577
7/5/2022	Alan H. Auerbach	CEO	Sell	26,140	$2.63	$68,748.20	6,317,952
7/5/2022	Douglas M. Hunt	Insider	Sell	3,753	$2.63	$9,870.39	77,730
7/5/2022	Maximo F. Nougues	CFO	Sell	5,835	$2.63	$15,346.05	64,625
6/16/2022	Troy Edward Wilson	Director	Sell	27,858	$2.58	$71,873.64	27,350
6/2/2022	Alan H. Auerbach	CEO	Sell	1,200	$1.94	$2,328.00	6,344,092
6/2/2022	Alvin F. Wong	Insider	Sell	587	$1.92	$1,127.04	61,447
6/2/2022	Maximo F. Nougues	CFO	Sell	162	$1.92	$311.04	121,066
5/3/2022	Alan H. Auerbach	CEO	Sell	1,263	$2.32	$2,930.16	6,345,292
5/3/2022	Douglas M. Hunt	Insider	Sell	438	$2.31	$1,011.78	81,900
5/3/2022	Maximo F. Nougues	CFO	Sell	165	$2.34	$386.10	121,228
4/4/2022	Alan H. Auerbach	CEO	Sell	1,198	$3.08	$3,689.84	6,346,555
3/2/2022	Alan H. Auerbach	CEO	Sell	1,294	$2.26	$2,924.44
3/2/2022	Douglas M. Hunt	Insider	Sell	446	$2.26	$1,007.96
3/2/2022	Maximo F. Nougues	CFO	Sell	169	$2.26	$381.94
2/2/2022	Alan H. Auerbach	CEO	Sell	1,316	$2.46	$3,237.36
2/2/2022	Douglas M. Hunt	Insider	Sell	533	$2.47	$1,316.51
2/2/2022	Maximo F. Nougues	CFO	Sell	199	$2.48	$493.52
1/3/2022	Alan H. Auerbach	CEO	Sell	22,875	$3.19	$72,971.25
1/3/2022	Douglas M. Hunt	Insider	Sell	3,707	$3.21	$11,899.47
1/3/2022	Maximo F. Nougues	CFO	Sell	7,484	$3.19	$23,873.96
12/2/2021	Alan H. Auerbach	CEO	Sell	1,837	$2.90	$5,327.30
12/2/2021	Alvin F. Wong	Insider	Sell	1,131	$2.91	$3,291.21
12/2/2021	Maximo F. Nougues	CFO	Sell	162	$2.95	$477.90
11/2/2021	Alan H. Auerbach	CEO	Sell	1,795	$5.63	$10,105.85
11/2/2021	Douglas M. Hunt	Insider	Sell	427	$5.64	$2,408.28
11/2/2021	Maximo F. Nougues	CFO	Sell	156	$5.67	$884.52
10/4/2021	Alan H. Auerbach	CEO	Sell	1,858	$6.15	$11,426.70
10/4/2021	Douglas M. Hunt	Insider	Sell	443	$6.15	$2,724.45
10/4/2021	Maximo F. Nougues	CFO	Sell	161	$6.20	$998.20
9/2/2021	Alan H. Auerbach	CEO	Sell	1,764	$7.60	$13,406.40	4,417,790
9/2/2021	Douglas M. Hunt	Insider	Sell	422	$7.52	$3,173.44
9/2/2021	Maximo F. Nougues	CFO	Sell	155	$7.51	$1,164.05
8/2/2021	Alan H. Auerbach	CEO	Sell	1,764	$7.53	$13,282.92
8/2/2021	Douglas M. Hunt	Insider	Sell	420	$7.53	$3,162.60	66,523
8/2/2021	Maximo F. Nougues	CFO	Sell	154	$7.54	$1,161.16
7/2/2021	Alan H. Auerbach	CEO	Sell	5,332	$8.84	$47,134.88
7/2/2021	Douglas M. Hunt	Insider	Sell	1,016	$9.15	$9,296.40	66,943
7/2/2021	Maximo F. Nougues	CFO	Sell	155	$9.26	$1,435.30
6/10/2021	Ann Calby Miller	Director	Sell	12,874	$11.43	$147,149.82	12,874
6/2/2021	Alan H. Auerbach	CEO	Sell	1,757	$10.74	$18,870.18	4,426,650
6/2/2021	Douglas M. Hunt	Insider	Sell	416	$10.77	$4,480.32	67,959
5/3/2021	Alan H. Auerbach	CEO	Sell	1,758	$9.01	$15,839.58	4,428,407
5/3/2021	Douglas M. Hunt	Insider	Sell	417	$9.91	$4,132.47	68,375
5/3/2021	Maximo F. Nougues	CFO	Sell	152	$9.91	$1,506.32	68,370

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here

SEC Filings (Institutional Ownership Changes) for Puma Biotechnology (NASDAQ:PBYI)

61.29% of Puma Biotechnology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Puma Biotechnology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/23/2024	Rice Hall James & Associates LLC	140,106	$0.74M	0.0%	-57.5%	0.291%
2/15/2024	Great Point Partners LLC	1,093,273	$4.73M	0.8%	N/A	2.298%
2/12/2024	Crestline Management LP	34,774	$0.15M	0.0%	+6.5%	0.073%
2/7/2024	Jump Financial LLC	57,200	$0.25M	0.0%	+131.7%	0.120%
1/31/2024	Federated Hermes Inc.	161,540	$0.70M	0.0%	-11.2%	0.340%
1/18/2024	Ritholtz Wealth Management	15,178	$66K	0.0%	N/A	0.032%
1/17/2024	Assenagon Asset Management S.A.	85,039	$0.37M	0.0%	+23.0%	0.179%
12/6/2023	Citigroup Inc.	99,767	$0.26M	0.0%	N/A	0.210%
11/15/2023	GSA Capital Partners LLP	279,629	$0.74M	0.1%	+143.8%	0.588%
11/13/2023	Acadian Asset Management LLC	1,858,000	$4.88M	0.0%	-0.9%	3.906%
11/7/2023	Jump Financial LLC	24,690	$65K	0.0%	+26.6%	0.052%
11/6/2023	Assenagon Asset Management S.A.	69,142	$0.18M	0.0%	-69.0%	0.146%
11/4/2023	LSV Asset Management	86,651	$0.23M	0.0%	-55.5%	0.182%
11/2/2023	Rice Hall James & Associates LLC	363,666	$0.96M	0.1%	-2.0%	0.765%
10/24/2023	Bank of New York Mellon Corp	52,923	$0.14M	0.0%	-26.8%	0.111%
10/19/2023	Patriot Financial Group Insurance Agency LLC	67,000	$0.18M	0.0%	-7.8%	0.141%
8/21/2023	Affinity Asset Advisors LLC	202,349	$0.71M	0.2%	+14.1%	0.426%
8/8/2023	Prospera Financial Services Inc	108,448	$0.38M	0.0%	+8.4%	0.232%
7/25/2023	Assenagon Asset Management S.A.	223,321	$0.79M	0.0%	+15.6%	0.478%
7/24/2023	Rice Hall James & Associates LLC	371,034	$1.31M	0.1%	+1.0%	0.794%
5/15/2023	Affinity Asset Advisors LLC	177,349	$0.55M	0.2%	N/A	0.380%
5/12/2023	Rice Hall James & Associates LLC	367,497	$1.14M	0.1%	-4.1%	0.787%
5/11/2023	Acadian Asset Management LLC	1,874,859	$5.79M	0.0%	+3.4%	4.014%
5/11/2023	Cornercap Investment Counsel Inc.	124,919	$0.39M	0.1%	N/A	0.267%
5/8/2023	Federated Hermes Inc.	191,063	$0.59M	0.0%	-45.5%	0.409%
5/8/2023	Bailard Inc.	14,102	$44K	0.0%	-73.6%	0.030%
5/3/2023	Jump Financial LLC	34,900	$0.11M	0.0%	-25.5%	0.075%
5/2/2023	LSV Asset Management	194,551	$0.60M	0.0%	-3.3%	0.417%
4/20/2023	Patriot Financial Group Insurance Agency LLC	36,000	$0.11M	0.0%	+26.3%	0.077%
4/18/2023	Assenagon Asset Management S.A.	193,194	$0.60M	0.0%	+16.3%	0.414%
3/28/2023	Acrisure Capital Management LLC	25,409	$0.11M	0.1%	N/A	0.054%
2/14/2023	683 Capital Management LLC	36,500	$0.15M	0.0%	N/A	0.080%
2/13/2023	GSA Capital Partners LLP	72,940	$0.31M	0.0%	-48.0%	0.160%
2/10/2023	Globeflex Capital L P	561,530	$2.38M	0.3%	-1.6%	1.230%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	183,270	$0.78M	0.0%	+22.8%	0.402%
2/8/2023	LSV Asset Management	201,151	$0.85M	0.0%	+10.5%	0.441%
2/8/2023	Prospera Financial Services Inc	88,322	$0.37M	0.0%	+7.4%	0.194%
2/7/2023	AlphaCentric Advisors LLC	50,000	$0.21M	0.2%	-88.0%	0.110%
2/7/2023	Commonwealth Equity Services LLC	10,859	$45K	0.0%	N/A	0.024%
2/1/2023	Bank of Montreal Can	32,265	$0.15M	0.0%	N/A	0.071%
1/27/2023	Rice Hall James & Associates LLC	383,218	$1.62M	0.1%	-1.1%	0.840%
1/17/2023	Patriot Financial Group Insurance Agency LLC	28,500	$0.12M	0.0%	-43.6%	0.062%
11/15/2022	Kynam Capital Management LP	559,769	$1.33M	0.3%	-3.5%	1.226%
11/15/2022	Brandywine Global Investment Management LLC	318,601	$0.76M	0.0%	-3.6%	0.698%
11/14/2022	Armistice Capital LLC	1,000,000	$2.37M	0.0%	-33.3%	2.191%
11/14/2022	Renaissance Technologies LLC	1,799,662	$4.27M	0.0%	-9.0%	3.943%
11/14/2022	Ergoteles LLC	122,609	$0.29M	0.0%	-14.3%	0.269%
11/14/2022	Hsbc Holdings PLC	18,913	$45K	0.0%	-18.8%	0.041%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	149,294	$0.35M	0.0%	+92.4%	0.327%
11/8/2022	AlphaCentric Advisors LLC	415,000	$0.98M	1.0%	N/A	0.909%
11/7/2022	LSV Asset Management	182,099	$0.43M	0.0%	N/A	0.400%
11/4/2022	Russell Investments Group Ltd.	99,139	$0.23M	0.0%	-17.5%	0.218%
11/1/2022	Rice Hall James & Associates LLC	387,539	$0.92M	0.1%	-23.4%	0.851%
11/1/2022	Patriot Financial Group Insurance Agency LLC	50,500	$0.12M	0.0%	-9.0%	0.111%
10/27/2022	Prospera Financial Services Inc	82,247	$0.20M	0.0%	+12.0%	0.181%
10/27/2022	Assenagon Asset Management S.A.	166,106	$0.39M	0.0%	-11.4%	0.365%
10/17/2022	Cambridge Investment Research Advisors Inc.	14,945	$35K	0.0%	N/A	0.033%
9/16/2022	Federated Hermes Inc.	351,117	$1M	0.0%	+3.1%	0.771%
8/12/2022	Brandywine Global Investment Management LLC	330,500	$0.94M	0.0%	-13.0%	0.725%
8/10/2022	Gladius Capital Management LP	9,811	$28K	0.0%	N/A	0.022%
8/8/2022	Walleye Capital LLC	104,223	$0.30M	0.0%	-52.4%	0.232%
8/8/2022	Rice Hall James & Associates LLC	506,066	$1.44M	0.1%	-1.0%	1.125%
8/8/2022	Prospera Financial Services Inc	73,424	$0.21M	0.0%	+23.0%	0.163%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	77,591	$0.22M	0.0%	-14.5%	0.173%
7/29/2022	Russell Investments Group Ltd.	120,099	$0.34M	0.0%	-30.5%	0.267%
7/27/2022	Bailard Inc.	53,500	$0.15M	0.0%	N/A	0.119%
7/27/2022	Assenagon Asset Management S.A.	187,490	$0.53M	0.0%	+651.2%	0.417%
7/12/2022	Diversified Trust Co	20,175	$57K	0.0%	-21.3%	0.045%
5/27/2022	Walleye Capital LLC	218,917	$0.63M	0.0%	-45.7%	0.487%
5/26/2022	Rice Hall James & Associates LLC	511,233	$1.47M	0.1%	+4.1%	1.137%
5/17/2022	Western Standard LLC	141,614	$0.33M	0.3%	N/A	0.315%
5/16/2022	Eversept Partners LP	1,424,650	$4.10M	0.3%	+27.4%	3.168%
5/13/2022	Kynam Capital Management LP	653,445	$1.88M	0.6%	-4.4%	1.453%
5/12/2022	Acadian Asset Management LLC	1,691,899	$4.87M	0.0%	-3.1%	3.762%
5/12/2022	Pitcairn Co.	27,558	$79K	0.0%	N/A	0.061%
5/12/2022	Running Point Capital Advisors LLC	10,000	$29K	0.0%	N/A	0.022%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	90,731	$0.26M	0.0%	-9.5%	0.202%
5/11/2022	GSA Capital Partners LLP	138,943	$0.40M	0.1%	N/A	0.309%
5/6/2022	Los Angeles Capital Management LLC	123,970	$0.36M	0.0%	+5.3%	0.276%
5/5/2022	Rice Hall James & Associates LLC	511,233	$1.47M	0.1%	+4.1%	1.137%
5/5/2022	Russell Investments Group Ltd.	172,732	$0.50M	0.0%	+78.2%	0.384%
5/4/2022	Prospera Financial Services Inc	59,680	$0.17M	0.0%	+65.6%	0.144%
4/27/2022	Dupont Capital Management Corp	65,242	$0.19M	0.0%	-8.1%	0.158%
4/25/2022	Assenagon Asset Management S.A.	24,959	$72K	0.0%	-93.4%	0.060%
3/3/2022	Walleye Capital LLC	403,119	$1.23M	0.0%	N/A	0.986%
2/25/2022	AlphaCentric Advisors LLC	400,000	$1.22M	0.4%	N/A	0.978%
2/14/2022	Rice Hall James & Associates LLC	491,282	$1.49M	0.1%	-10.1%	1.202%
2/14/2022	Eversept Partners LP	1,117,898	$3.40M	0.3%	+180.9%	2.734%
2/11/2022	Renaissance Technologies LLC	1,820,858	$5.54M	0.0%	+11.6%	4.453%
2/11/2022	Bank of Montreal Can	557,538	$1.82M	0.0%	+120.3%	1.364%
2/10/2022	Acadian Asset Management LLC	1,746,281	$5.31M	0.0%	+34.4%	4.271%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	100,215	$0.31M	0.0%	N/A	0.245%
2/9/2022	Principal Financial Group Inc.	50,445	$0.15M	0.0%	+13.2%	0.123%
2/8/2022	Northern Trust Corp	305,164	$0.93M	0.0%	-12.8%	0.746%
2/3/2022	Advisor Group Holdings Inc.	15,571	$49K	0.0%	-46.7%	0.038%
2/3/2022	Los Angeles Capital Management LLC	117,681	$0.36M	0.0%	-17.7%	0.288%
2/2/2022	New York State Common Retirement Fund	28,399	$86K	0.0%	+49.1%	0.069%
2/1/2022	Assenagon Asset Management S.A.	379,139	$1.15M	0.0%	N/A	0.927%
1/31/2022	Dupont Capital Management Corp	71,012	$0.22M	0.0%	N/A	0.174%
1/28/2022	Allspring Global Investments Holdings LLC	247,200	$0.75M	0.0%	N/A	0.605%

Data available starting January 2016

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. The company sells its products through specialty pharmacy and distributor networks. It has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds; and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of alisertib, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.

Today's Range

Now: $5.13

$5.10

$5.34

50 Day Range

MA: $5.66

$4.30

$7.40

52 Week Range

Now: $5.13

$2.13

$7.73

Volume

293,866 shs

Average Volume

323,505 shs

Market Capitalization

$247.32 million

P/E Ratio

11.15

Dividend Yield

N/A

Beta

1.28

Who are the company insiders with the largest holdings of Puma Biotechnology?: Puma Biotechnology's top insider shareholders include:
Alan H Auerbach (CEO)
Maximo F Nougues (CFO)
Alvin F Wong (Insider)
Douglas M Hunt (Insider)
Michael Patrick Miller (Director)
Troy Edward Wilson (Director)
Learn More about top insider investors at Puma Biotechnology.
Who are the major institutional investors of Puma Biotechnology?: Puma Biotechnology's top institutional investors include:
Rice Hall James & Associates LLC — 0.29%
Assenagon Asset Management S.A. — 0.15%
Learn More about top institutional investors of Puma Biotechnology stock.
Which major investors are selling Puma Biotechnology stock?: Within the last quarter, PBYI stock was sold by these institutional investors:
Rice Hall James & Associates LLC
Assenagon Asset Management S.A.
During the previous year, company insiders that have sold Puma Biotechnology company stock include:
Alan H Auerbach (CEO)
Maximo F Nougues (CFO)
Alvin F Wong (Insider)
Douglas M Hunt (Insider)
Michael Patrick Miller (Director)
Learn More investors selling Puma Biotechnology stock.

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here

PBYI Insider Trading

Puma Biotechnology Insider Trading History Chart

Puma Biotechnology Share Price & Price History

Puma Biotechnology Insider Trading History

SEC Filings (Institutional Ownership Changes) for Puma Biotechnology (NASDAQ:PBYI)

Institutional Buying and Selling by Quarter

Puma Biotechnology Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Puma Biotechnology?

Who are the major institutional investors of Puma Biotechnology?

Which major investors are selling Puma Biotechnology stock?